SS Innovations' SSi Mantra system completed the world's first dual-console, beating-heart TECAB surgery using all five arms at Medanta Hospital in Gurugram, India. Dr. Nitin Kumar Rajput and Dr. Lalit Malik performed the procedure under Dr. Sudhir Srivastava's guidance.
SSII · SS Innovations International, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited interim condensed consolidated financial statements are issued.”View the 10-Q filed Nov 16, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Close
- $1.28
- Open
- $1.31
- Day range
- $1.18–1.35
- 52-week closing range
- $1.28–6.73
- Average volume, 30 days
- 113K
- Short interest
- 64K · 0.0% of shares · 1.1 days
- Short volume, last session
- 72%
- Last earnings
- Oct 28, 2025
- Latest filing
- 10-Q · Nov 16
- Price history
- Aug 2024 to Nov 2026
Latest documents
SS Innovations International's Chairman and CEO Dr. Sudhir Srivastava, through Sushruta Pvt. Ltd., bought 100,000 common shares at $3.00 per share on November 17, 2026, paying $300,000 by exchanging accrued unpaid compensation owed to him.
SS Innovations reported three-month revenue of $6,331,061, down from $12,829,349 a year earlier, as net loss widened to $5,749,389 from $3,717,964. Research and development expense rose to $2,500,826 on regulatory and clinical trial costs.
SS Innovations International, Inc. appointed Gary G. Lo CFO and Vishwajyoti P. Srivastava President, effective November 6, 2026. Srivastava will lead U.S. and European regulatory efforts for SSi Mantra; Lo’s annual base salary is $400,000.
SS Innovations showcased its SSi Mantra system in successful October 2026 telesurgeries at EACTS in Barcelona and SRS India in New Delhi. As of October 23, 2026, 205 telesurgeries have been performed with the SSi Mantra system.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cumulative cardiac procedures | 637 | As of June 30, 2026 | — |
| Cumulative pediatric surgeries | 222 | As of June 30, 2026 | — |
| Cumulative surgeries | 12,272 | As of June 30, 2026 | — |
| Cumulative telesurgeries | 175 | As of June 30, 2026 | — |
| SSi Mantra cumulative installed base | 224 | As of June 30, 2026 | — |
| SSi Mantra surgeries | 4,387 | H1 2026 | — |
| SSi Mantra surgical robotic system installations | 56 | H1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SSII
this stock
SS Innovations International, Inc.
|
$256.74M | -77.5% | +105.7% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$179.90B | -17.1% | +5.7% | 38.8 | 1.1% |
|
MDT
Medtronic plc
|
$128.69B | +4.7% | +8.4% | 24.8 | 1.8% |
|
SYK
Stryker Corp
|
$119.19B | -10.9% | +11.2% | 33.3 | 1.7% |
|
BSX
Boston Scientific Corp
|
$62.31B | -54.9% | +12.5% | 18.2 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 19, 2026
- This year
- 37
SS Innovations' SSi Mantra system completed the world's first dual-console, beating-heart TECAB surgery using all five arms at Medanta Hospital in Gurugram, India. Dr. Nitin Kumar Rajput and Dr. Lalit Malik performed the procedure under Dr. Sudhir Srivastava's guidance.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SSII | -3.0% | -46.0% | -67.5% | -45.5% | -77.5% |
| SPY | -5.5% | -6.3% | -5.6% | -5.3% | +5.0% |
| vs SPY | +2.4% | -39.7% | -61.9% | -40.3% | -82.4% |